- Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
-
Choi R, Jeong BH, Koh WJ, Lee SY
- KMID: 2373626
- Ann Lab Med.
- 2017 Mar;37(2):97-107.
- doi: 10.3343/alm.2017.37.2.97
Although tuberculosis is largely a curable disease, it remains a major cause of morbidity and mortality worldwide. Although the standard 6-month treatment regimen is highly effective for drug-susceptible tuberculosis, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines
-
Kim S, Yun YM, Chae HJ, Cho HJ, Ji M, Kim IS, Wee KA, Lee W, Song SH, Woo HI, Lee SY, Chun S
- KMID: 2373642
- Ann Lab Med.
- 2017 Mar;37(2):180-193.
- doi: 10.3343/alm.2017.37.2.180
Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended... -
- CITED
-
- Close
- SHARE
-
- Close
- Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 Polymorphisms and the Risk of Gastric Cancer
-
Hong SH, Kim JW, Kim HG, Park IK, Ryoo JW, Lee CH, Sohn YK, Lee JY
- KMID: 792400
- J Prev Med Public Health.
- 2006 Mar;39(2):135-140.
OBJECTIVES: Polymorphisms of genes from glutathione Stransferases (GSTs) and N-acetyltransferase 2 (NAT2) have been associated with increased susceptibility to various cancers. Previous results showed that East Asians such as... -
- CITED
-
- Close
- SHARE
-
- Close
